N/A
Completed N=410
Real-life Data From Diabetic Patients on Closed-loop Pumps
Source: ClinicalTrials.gov NCT05418699 ↗Enrolled (actual)
410
Serious AEs
6.3%
Results posted
Mar 2026
Primary outcomePrimary: HbA1c Level — 6.9 percentage of HBA1c
Summary
To evaluate, in real life, the effect of closed-loop devices on the improvement of glycemic control in diabetic patients managed in the endocrinology departments of secondary care hospitals.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HbA1c Level |
7.1 | — |
| SECONDARY HbA1c Level |
7.1 | — |
| SECONDARY Time in Range |
73 | — |
| SECONDARY Time Below Range |
2 | — |
| SECONDARY Time Above Range |
24 | — |
| SECONDARY Coefficient of Variation |
33 | — |
Eligibility Criteria
Inclusion Criteria
- type I diabetic
- with a closed-loop insulin pump
Exclusion Criteria
- under legal protection order
- patient or legal guardian objecting to the use of the data in the research
Data sourced from ClinicalTrials.gov (NCT05418699). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.